Blaž Rozman

发表

EULAR randomised controlled trial of pulse cyclophosphamide and methylprednisolone versus continuous cyclophosphamide and prednisolone followed by azathioprine and prednisolone in lupus nephritis

C. Gordon, D. Isenberg, O. Nived, 2004, Annals of the rheumatic diseases.

Investigation of the influence of CYP1A2 and CYP2C19 genetic polymorphism on A771726 pharmacokinetics in leflunomide treated patients with rheumatoid arthritis

A. Mrhar, B. Rozman, D. Logar, 2009 .

Development of patient-centred standards of care for osteoarthritis in Europe: the eumusc.net-project

M. Dougados, A. Woolf, A. Boonen, 2014, Annals of the rheumatic diseases.

The avidity of anti-β2-glycoprotein I antibodies in patients with or without antiphospholipid syndrome: a collaborative study in the frame of the European forum on antiphospholipid antibodies

S. Čučnik, T. Kveder, B. Božič, 2011, Lupus.

Parasympathetic nervous system dysfunction in primary Sjögren’s syndrome

T. Kveder, M. Tomšič, S. Praprotnik, 2003, Annals of the rheumatic diseases.

A multicentre, randomised, double blind, placebo controlled phase II study of subcutaneous interferon beta-1a in the treatment of patients with active rheumatoid arthritis

G. Herrero-Beaumont, P. Tak, M. Genovese, 2004, Annals of the rheumatic diseases.

Prognostic value of contrast enhanced Gd-DTPA MRI for development of bone erosive changes in rheumatoid arthritis.

V. Jevtič, F. Demsar, M. Tomšič, 1996, British journal of rheumatology.

Prevalence and clinical associations of anti-Ku antibodies in patients with systemic sclerosis: a European EUSTAR-initiated multi-centre case–control study

M. Aringer, L. Czirják, S. Čučnik, 2007, Annals of the rheumatic diseases.

High avidity anti-b2-glycoprotein I antibodies in patients with antiphospholipid syndrome

T. Kveder, C. Alessandri, A. Artenjak, 2004 .

Incidence of primary Sjögren’s syndrome in Slovenia

T. Kveder, M. Tomšič, A. Hočevar, 2004, Annals of the rheumatic diseases.

Dihydroorotate dehydrogenase polymorphism influences the toxicity of leflunomide treatment in patients with rheumatoid arthritis

S. Praprotnik, B. Rozman, D. Logar, 2009, Annals of the rheumatic diseases.